Zepbound is ... Prescription weight loss medications may be useful for people looking to lose weight or maintain their weight loss when combined with a well-balanced diet and exercise routine.

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound ... weight loss compared to 16.1% of those receiving semaglutide, according to Lilly, which said it plans ...

In the glittering world of celebrity-endorsed weight loss transformations and viral before-and-after photos, a darker narrative is emerging from the shadows ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

You must also follow a calorie-restricted diet and an exercise plan while using tirzepatide ... Tirzepatide is FDA-approved for weight loss as the brand-name drug Zepbound. It is also FDA-approved ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

About 140,400 obese patients in Massachusetts were prescribed medications such as Wegovy and Zepbound in 2024 ... As it turns out, her plan excludes payment for weight-loss drugs.

(Reuters) - Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales of popular weight-loss drug Zepbound after it last month ...